Form 4: Rhythm Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals, sold 18,235 shares of common stock on March 21, 2024, to cover withholding taxes related to vesting restricted stock units.

Summary

• On March 21, 2024, Joseph Shulman, the Chief Technical Officer of Rhythm Pharmaceuticals, sold 18,235 shares of the company's common stock.
• The sale was executed to cover withholding taxes associated with the vesting of previously reported restricted stock units.
• The shares were sold at a weighted average price of $40.34, with individual transactions ranging from $40.00 to $40.89 per share.
• Following the transaction, Mr. Shulman still directly owns 30 shares of Rhythm Pharmaceuticals stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax purposes) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading activity and are required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.

Key Dates